Cargando…
Top research priorities in liver and gallbladder disorders in the UK
OBJECTIVES: There is a mismatch between research questions considered important by patients, carers and healthcare professionals and the research performed in many fields of medicine. The non-alcohol-related liver and gallbladder disorders priority setting partnership was established to identify the...
Autores principales: | Gurusamy, Kurinchi S, Walmsley, Martine, Davidson, Brian R, Frier, Claire, Fuller, Barry, Madden, Angela, Masson, Steven, Morley, Richard, Safarik, Ivana, Tsochatzis, Emmanuel A, Ahmed, Irfan, Cowlin, Maxine, Dillon, John F, Ellicott, Graham, Elsharkawy, Ahmed M, Farrington, Liz, Glachan, Anthony, Kumar, Nagappan, Milne, E J, Rushbrook, Simon M, Smith, Amanda, Stafford, Lizzie, Yeoman, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429888/ https://www.ncbi.nlm.nih.gov/pubmed/30850408 http://dx.doi.org/10.1136/bmjopen-2018-025045 |
Ejemplares similares
-
Rare but heard: using asynchronous virtual focus groups, interviews and roundtable discussions to create a personalised psychological intervention for primary sclerosing cholangitis: a protocol
por: Ranieri, Veronica, et al.
Publicado: (2019) -
Mixed-methods evaluation of point-of-care hepatitis C virus RNA testing in a Scottish prison
por: Byrne, Christopher J, et al.
Publicado: (2023) -
Clinical effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: a study protocol for a pragmatic cluster randomised trial
por: Radley, Andrew, et al.
Publicado: (2018) -
Bangladesh Environmental Enteric Dysfunction (BEED) study: protocol for a community-based intervention study to validate non-invasive biomarkers of environmental enteric dysfunction
por: Mahfuz, Mustafa, et al.
Publicado: (2017) -
Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH)
por: Brennan, Paul Noel, et al.
Publicado: (2021)